We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas

This study has been terminated.
(Modified dose schedule presented no advantage over previously studied schedule)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00955292
First Posted: August 10, 2009
Last Update Posted: August 10, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Cylene Pharmaceuticals
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2008
  Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)